Literature DB >> 8608290

Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants.

D Goldblatt1, C K Fairley, K Cartwright, E Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8608290      PMCID： PMC2350736          DOI： 10.1136/bmj.312.7034.817

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.

Authors:  D M Granoff; E L Anderson; M T Osterholm; S J Holmes; J E McHugh; R B Belshe; F Medley; T V Murphy
Journal:  J Pediatr       Date:  1992-08       Impact factor: 4.406

2.  Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.

Authors:  R Booy; S A Taylor; S R Dobson; D Isaacs; G Sleight; S Aitken; H Griffiths; H Chapel; R T Mayon-White; J A Macfarlane
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

3.  The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  H Käyhty; H Peltola; V Karanko; P H Mäkelä
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

4.  Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.

Authors:  R Booy; S Hodgson; L Carpenter; R T Mayon-White; M P Slack; J A Macfarlane; E A Haworth; M Kiddle; S Shribman; J S Roberts
Journal:  Lancet       Date:  1994-08-06       Impact factor: 79.321
  4 in total
  3 in total

1.  Initiatives to improve childhood immunisation uptake: a randomised controlled trial.

Authors:  M Z Morgan; M R Evans
Journal:  BMJ       Date:  1998-05-23

2.  Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.

Authors:  P Richmond; R Borrow; J Findlow; S Martin; C Thornton; K Cartwright; E Miller
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Antibody responses to Haemophilus influenzae type b conjugate vaccine in sickle cell disease.

Authors:  D Goldblatt; M Johnson; J Evans
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.